ENANTA PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2012 to Q3 2024.
  • Enanta Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 21.2M shares, a 0.9% increase year-over-year.
  • Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 21.2M shares, a 0.9% increase from 2023.
  • Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 21M shares, a 1.78% increase from 2022.
  • Enanta Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 20.6M shares, a 2.14% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 21.2M +188K +0.9% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-27
Q2 2024 21.2M +126K +0.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 21.2M +132K +0.63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 21.1M +272K +1.31% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 21M +366K +1.78% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-27
Q2 2023 21.1M +344K +1.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 21M +484K +2.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 20.8M +428K +2.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 20.6M +432K +2.14% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-27
Q2 2022 20.7M +509K +2.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 20.6M +380K +1.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 20.4M +295K +1.47% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 20.2M +231K +1.16% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-22
Q2 2021 20.2M +181K +0.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 20.2M +249K +1.25% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 20.1M -680K -3.27% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 19.9M -1.03M -4.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-23
Q2 2020 20M -1.09M -5.14% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 19.9M -1.16M -5.51% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 20.8M -37K -0.18% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 21M +318K +1.54% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-24
Q2 2019 21.1M +88K +0.42% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 21.1M +483K +2.35% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 20.8M +892K +4.48% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 20.7M +1.24M +6.41% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-25
Q2 2018 21M +1.94M +10.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 20.6M +1.55M +8.16% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 19.9M +880K +4.62% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-08
Q3 2017 19.4M +183K +0.95% Jul 1, 2017 Sep 30, 2017 10-K 2019-11-27
Q2 2017 19.1M +98K +0.52% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 19M +126K +0.67% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 19M -231K -1.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 19.2M -71K -0.37% Jul 1, 2016 Sep 30, 2016 10-K 2018-11-29
Q2 2016 19M -295K -1.53% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 18.9M -348K -1.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 19.3M -14.2K -0.07% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 19.3M +110K +0.57% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-11
Q2 2015 19.3M +74.7K +0.39% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 19.3M +915K +4.99% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 19.3M +1.33M +7.43% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 19.2M +9.4M +96% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-09
Q2 2014 19.2M +1.38M +7.76% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 18.4M +16.2M +737% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 17.9M +15.3M +581% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 9.79M Jul 1, 2013 Sep 30, 2013 10-K 2015-12-11
Q2 2013 17.8M +16.7M +1490% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 2.19M -344K -13.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 2.64M Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-13
Q2 2012 1.12M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 2.54M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.